Skip to main content

This job has expired

Post-doctoral Fellow in Cancer Immunology and Stem Cell Engineering

Employer
THE UNIVERSITY OF HONG KONG
Location
Pok Fu Lam, Hong Kong
Closing date
31 Mar 2022

Work type: Full-time
Department: School of Biomedical Sciences (22600)
Categories: Academic-related Staff

Applications are invited for appointment as Post-doctoral Fellow in Cancer Immunology & Stem Cell Engineering of the School of Biomedical Sciences (Ref.: 511522), to commence as soon as possible for one year, with the possibility of renewal.

Applicants should have a Ph.D. degree in Immunology, Cancer Biology/Pharmacology or related fields, with experience in cancer immunology, stem cell engineering, and other relevant areas through participating in translational research projects aimed at applying stem cell technology to engineer immune cells for remodeling tumor microenvironment. Research projects involve, but not limited to: i) the design and production of chimeric antigen receptor (CAR)-immune cells from pluripotent stem cells; ii) the lineage trajectory of an elite clone of CAR-immune cells at the single-cell level; and iii) the responses at the CAR-immune cells by tumor microenvironment of hepatocellular carcinoma.  Applicants should have strong interpersonal skills, a track record of collaborative work in multidisciplinary research environments, and mastery of written and spoken English; and be able to work independently and in a collaborative team.  Enquiries about the post should be sent to Dr. Rio Sugimura at rios@hku.hk. Applicants who have responded to the previous advertisement (Ref.: 508505) need not re-apply.

Dr. Rio Sugimura, Assistant Professor in the School, is an internationally recognized stem cell engineer, whose research focuses on the engineering of immune cells to target hepatocellular carcinoma, and the regulation of immune cells in the tumor microenvironment. Dr. Sugimura is also a Principal Investigator of the Centre of Translational Stem Cell Biology at the Science Park, Hong Kong; and the Director of The Blood Engineering Lab (BEL). The BEL was established in December 2020 which hosts an interdisciplinary environment of cancer immunology, stem cell technology, and informatics. Though a relatively young group, the BEL attracted a wealth of external grants and international collaborations, and grew up to ten members within half a year.

A highly competitive salary commensurate with qualifications and experience will be offered, in addition to annual leave and medical benefits.

The University only accepts online applications for the above post.  Applicants should apply online and upload an up-to-date C.V.  Review of applications will start as soon as possible and continue until March 31, 2022, or until the post is filled, whichever is earlier.

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert